Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine vs Metformin for Metabolic Syndrome in Schizophrenia
NCT03708549Phase 4Unknown
- Sponsor
- Tianjin Anding Hospital
- Start
- Dec 2021
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of berberine in metabolic syndrome, sponsored by Tianjin Anding Hospital. Status: unknown.
02
Drugs
berberine
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT03708549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03708549.